Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 620.55
-9.85 (-1.56%)
Nov 12, 2026, 3:29 PM IST
NSE:NEPHROPLUS Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 2,445 | 1,239 | 1,259 | 611.51 | 140.6 | 1,281 |
Short-Term Investments | 2,048 | 1,310 | 117.87 | 170.95 | 519.93 | - |
Trading Asset Securities | - | 1,706 | 507.55 | - | - | - |
Cash & Short-Term Investments | 4,493 | 4,256 | 1,884 | 782.46 | 660.53 | 1,281 |
Cash Growth | - | 125.86% | 140.81% | 18.46% | -48.42% | 101.62% |
Accounts Receivable | 3,275 | 3,169 | 2,664 | 2,027 | 1,585 | 917.57 |
Other Receivables | - | - | - | - | - | 97.24 |
Receivables | 3,275 | 3,169 | 2,664 | 2,027 | 1,585 | 1,015 |
Inventory | 473.83 | 330.37 | 266.23 | 259.13 | 262.71 | 143.36 |
Prepaid Expenses | - | 46.24 | 39.81 | 37.35 | 19.21 | 6.11 |
Restricted Cash | - | 286.29 | 269.91 | - | - | - |
Other Current Assets | 929.11 | 304.22 | 329.21 | 794.73 | 715.05 | 104.75 |
Total Current Assets | 9,171 | 8,392 | 5,454 | 3,900 | 3,243 | 2,550 |
Property, Plant & Equipment | 4,314 | 4,017 | 3,299 | 3,046 | 2,514 | 1,680 |
Long-Term Investments | 88.88 | 423.88 | 3.51 | - | 157.67 | 1,150 |
Goodwill | 912.83 | 866.93 | 555.1 | 409.5 | 187.07 | - |
Other Intangible Assets | 1,186 | 338.67 | 167.45 | 109.05 | 31.76 | 11.79 |
Long-Term Deferred Tax Assets | 391.93 | 339.61 | 205.68 | 236.32 | 166.52 | 157.68 |
Long-Term Deferred Charges | - | 30.38 | 30.45 | - | - | - |
Other Long-Term Assets | 268.98 | 300.19 | 249.97 | 359.03 | 362.99 | 169.92 |
Total Assets | 16,333 | 14,709 | 9,965 | 8,060 | 6,662 | 5,719 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1,596 | 1,430 | 1,129 | 705.32 | 432.78 | 149.53 |
Accrued Expenses | - | 294.88 | 108.85 | 101.68 | 96.48 | 73.72 |
Short-Term Debt | - | 132.28 | 1,011 | 930.09 | 916.36 | 297.52 |
Current Portion of Long-Term Debt | 795.29 | 97.44 | 286.9 | 271.12 | 230.9 | 203.85 |
Current Portion of Leases | 141.35 | 116.12 | 70.99 | 57.03 | 40.94 | 12.47 |
Current Income Taxes Payable | 105.01 | 166.52 | 53.45 | - | 4.41 | - |
Other Current Liabilities | 1,149 | 756.8 | 178.8 | 360.61 | 24.26 | 110.76 |
Total Current Liabilities | 3,788 | 2,994 | 2,839 | 2,426 | 1,746 | 847.85 |
Long-Term Debt | - | 0.47 | 959.98 | 1,232 | 814.82 | 651.82 |
Long-Term Leases | 552.95 | 450.76 | 248.76 | 187.75 | 134.25 | 31.66 |
Pension & Post-Retirement Benefits | - | 45.69 | 39.81 | 30.34 | 39.57 | 24.72 |
Long-Term Deferred Tax Liabilities | 32.76 | 35.48 | 20.38 | 3.67 | - | - |
Other Long-Term Liabilities | 70.43 | 17.22 | 15.59 | 43.03 | 41.22 | 43.1 |
Total Liabilities | 4,444 | 3,544 | 4,123 | 3,923 | 2,776 | 1,599 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 201.12 | 200.68 | 17.65 | 17.49 | 17.4 | 17.26 |
Additional Paid-In Capital | - | 10,225 | 6,066 | 5,087 | 5,060 | 5,032 |
Retained Earnings | - | 474.82 | -303.62 | -966.68 | -1,345 | -1,062 |
Comprehensive Income & Other | 11,689 | 264.91 | 24.69 | -34.65 | 120.22 | 98.13 |
Total Common Equity | 11,890 | 11,165 | 5,804 | 4,103 | 3,852 | 4,086 |
Shareholders' Equity | 11,890 | 11,165 | 5,841 | 4,137 | 3,886 | 4,120 |
Total Liabilities & Equity | 16,333 | 14,709 | 9,965 | 8,060 | 6,662 | 5,719 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 1,490 | 797.07 | 2,578 | 2,678 | 2,137 | 1,197 |
Net Cash (Debt) | 3,003 | 3,459 | -693.53 | -1,896 | -1,477 | 83.35 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 29.75 | 36.47 | -8.28 | -23.72 | -19.17 | 10.05 |
Filing Date Shares Outstanding | 100.39 | 100.34 | 18.09 | 10.34 | 10.04 | 8.97 |
Total Common Shares Outstanding | 100.39 | 100.34 | 10.42 | 10.34 | 10.04 | 8.97 |
Working Capital | 5,383 | 5,398 | 2,615 | 1,474 | 1,496 | 1,702 |
Book Value Per Share | 118.43 | 111.27 | 556.86 | 396.68 | 383.54 | 455.50 |
Tangible Book Value | 9,791 | 9,959 | 5,082 | 3,585 | 3,634 | 4,074 |
Tangible Book Value Per Share | 97.52 | 99.26 | 487.54 | 346.55 | 361.76 | 454.19 |
Buildings | - | 325.4 | 262.5 | 259.2 | 71.61 | - |
Machinery | - | 5,161 | 4,412 | 3,757 | 2,726 | 2,072 |
Construction In Progress | - | 55.38 | 58.42 | 6.87 | 316.49 | 19.68 |
Leasehold Improvements | - | 606.93 | 594.15 | 463.02 | 365.53 | 270.64 |